879 related articles for article (PubMed ID: 16120635)
21. Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment.
Caira M; Trecarichi EM; Mancinelli M; Leone G; Pagano L
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):881-92. PubMed ID: 21810058
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.
Camps IR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of opportunistic fungal infections in Latin America.
Nucci M; Queiroz-Telles F; Tobón AM; Restrepo A; Colombo AL
Clin Infect Dis; 2010 Sep; 51(5):561-70. PubMed ID: 20658942
[TBL] [Abstract][Full Text] [Related]
24. [Intra-abdominal mycoses].
Boos C; Kujath P; Bruch HP
Mycoses; 2005; 48 Suppl 1():22-6. PubMed ID: 15826283
[TBL] [Abstract][Full Text] [Related]
25. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
Erjavec Z; Kluin-Nelemans H; Verweij PE
Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
[TBL] [Abstract][Full Text] [Related]
26. Changing trends in the epidemiology of Candida blood stream infections: a matter for concern?
Sobel JD
Crit Care Med; 2010 Mar; 38(3):990-2. PubMed ID: 20168159
[No Abstract] [Full Text] [Related]
27. Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies.
Murali S; Langston A
Transpl Infect Dis; 2009 Dec; 11(6):480-90. PubMed ID: 19725908
[TBL] [Abstract][Full Text] [Related]
28. Incidence of fungal infections in a solid organ recipients dedicated intensive care unit.
Pugliese F; Ruberto F; Cappannoli A; Perrella SM; Bruno K; Martelli S; Marcellino V; D'Alio A; Diso D; Rossi M; Corradini SG; Morabito V; Rolla M; Ferretti G; Venuta F; Berloco PB; Coloni GF; Pietropaoli P
Transplant Proc; 2007; 39(6):2005-7. PubMed ID: 17692677
[TBL] [Abstract][Full Text] [Related]
29. [Early diagnosis of invasive fungal infections in hematooncological patients by serological methods].
Rácil Z; Kocmanová I; Wagnerová B; Lengerová M; Mayer J
Vnitr Lek; 2007 Sep; 53(9):990-9. PubMed ID: 18019671
[TBL] [Abstract][Full Text] [Related]
30. Fungal infections: a growing threat.
Dixon DM; McNeil MM; Cohen ML; Gellin BG; La Montagne JR
Public Health Rep; 1996; 111(3):226-35. PubMed ID: 8643813
[TBL] [Abstract][Full Text] [Related]
31. [Risk factors for invasive fungal infections during intensive chemotherapy of acute leukemia--retrospective study].
Zupanić-Krmek D; Nemet D; Mrsić M; Bogdanić V; Labar B; Jandrlić M; Kalenić S
Acta Med Croatica; 2004; 58(4):275-84. PubMed ID: 15700683
[TBL] [Abstract][Full Text] [Related]
32. [Prophylaxis of fungal infections in haematological patients: pro].
Glass B
Dtsch Med Wochenschr; 2010 Sep; 135(38):1870. PubMed ID: 20842607
[No Abstract] [Full Text] [Related]
33. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
34. [Drug resistance in the treatment of invasive fungal infections].
Nordøy I; Gaustad P
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2607-11. PubMed ID: 19023376
[TBL] [Abstract][Full Text] [Related]
35. A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999.
Lortholary O; Charlemagne A; Bastides F; Chevalier P; Datry A; Gonzalves MF; Michel G; Tilleul P; Veber B; Herbrecht R
J Antimicrob Chemother; 2004 Aug; 54(2):456-64. PubMed ID: 15231769
[TBL] [Abstract][Full Text] [Related]
36. [Prophylaxis of fungal infections in haematological patients: contra].
Schwartz S
Dtsch Med Wochenschr; 2010 Sep; 135(38):1871. PubMed ID: 20842608
[No Abstract] [Full Text] [Related]
37. Epidemiology of invasive fungal infection.
Castón-Osorio JJ; Rivero A; Torre-Cisneros J
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S103-9. PubMed ID: 19013332
[TBL] [Abstract][Full Text] [Related]
38. Antifungal treatment strategies in high risk patients.
Rüping MJ; Vehreschild JJ; Cornely OA
Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
[TBL] [Abstract][Full Text] [Related]
39. Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit.
Devlin RK
Adv Neonatal Care; 2006 Apr; 6(2):68-77; quiz 78-9. PubMed ID: 16618476
[TBL] [Abstract][Full Text] [Related]
40. Nosocomial fungal infections. Old problems and new challenges.
Anaissie E; Bodey GP
Infect Dis Clin North Am; 1989 Dec; 3(4):867-82. PubMed ID: 2687366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
